
NASDAQ:ABNB
This summary was created by AI, based on 2 opinions in the last 12 months.
Airbnb (ABNB) is experiencing a challenging phase characterized by intense competition and pricing pressures compared to traditional hotels and other alternatives. Experts have raised concerns about regulatory risks in various cities, as well as a significant shift in supply dynamics that has matured faster than anticipated. Although the company is trading at a forward price-to-earnings ratio of 25x, with expected growth rates of 10-12%, the long-term outlook seems uncertain due to factors like higher cancellation rates linked to their reserve now/pay later model. Some analysts prefer more diversified competitors such as Expedia (EXPE) or Booking Holdings (BKNG) which appear to be better managed and positioned within the market. The sentiment is somewhat lukewarm, reflecting a cautious optimism about ABNB's potential, yet an acknowledgment of the current challenges it faces.
Last week, the company cautioned the market about travel given the Delta variant, so the stock got slammed. Today, the stock jumped 2% on the FDA-Pfizer approval.